PTEN acetylation modulates its interaction with PDZ domain

被引:131
作者
Ikenoue, Tsuneo [2 ]
Inoki, Ken [2 ]
Zhao, Bin [1 ,3 ,4 ]
Guan, Kun-Liang [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
[4] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
关键词
D O I
10.1158/0008-5472.CAN-08-1107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The PTEN tumor suppressor gene is frequently inactivated in human cancer. As a major tumor suppressor, PTEN function must be tightly regulated. Both phosphorylation and membrane association have been reported to regulate PTEN activity. In addition, the COOH terminus of PTEN has a typical PDZ domain-binding motif that interacts with several PDZ domain-containing proteins. In this report, we show that PTEN is acetylated on Lys(402), which is in the COOH-terminal PDZ domain-binding motif. We show that CBP plays a major role in PTEN acetylation, whereas the SIRT1 deacetylase is mainly responsible for PTEN deacetylation. Interestingly, Lys(402) acetylation modulates PTEN interaction with PDZ domain-containing proteins, indicating a potential role of acetylation in regulating PTEN function.
引用
收藏
页码:6908 / 6912
页数:5
相关论文
共 18 条
[1]  
Adey NB, 2000, CANCER RES, V60, P35
[2]   Membrane-binding and activation mechanism of PTEN [J].
Das, S ;
Dixon, JE ;
Cho, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7491-7496
[3]  
Georgescu MM, 2000, CANCER RES, V60, P7033
[4]   Acetylation and deacetylation of non-histone proteins [J].
Glozak, MA ;
Sengupta, N ;
Zhang, XH ;
Seto, E .
GENE, 2005, 363 :15-23
[5]   Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes [J].
Heltweg, B ;
Gatbonton, T ;
Schuler, AD ;
Posakony, J ;
Li, HZ ;
Goehle, S ;
Kollipara, R ;
DePinho, RA ;
Gu, YS ;
Simon, JA ;
Bedalov, A .
CANCER RESEARCH, 2006, 66 (08) :4368-4377
[6]   SIRT1 is significantly elevated in mouse and human prostate cancer [J].
Huffman, Derek M. ;
Grizzle, William E. ;
Bamman, Marcas M. ;
Kim, Jeong-su ;
Eltoum, Isam A. ;
Elgavish, Ada ;
Nagy, Tim R. .
CANCER RESEARCH, 2007, 67 (14) :6612-6618
[7]   Acetylation: a regulatory modification to rival phosphorylation? [J].
Kouzarides, T .
EMBO JOURNAL, 2000, 19 (06) :1176-1179
[8]   Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association [J].
Lee, JO ;
Yang, HJ ;
Georgescu, MM ;
Di Cristofano, A ;
Maehama, T ;
Shi, YG ;
Dixon, JE ;
Pandolfi, P ;
Pavletich, NP .
CELL, 1999, 99 (03) :323-334
[9]  
MACHAMA T, 1998, J BIOL CHEM, V273, P13375
[10]   P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase [J].
Myers, MP ;
Stolarov, JP ;
Eng, C ;
Li, J ;
Wang, SI ;
Wigler, MH ;
Parsons, R ;
Tonks, NK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9052-9057